The severity of ILD (based on indicators such as pulmonary function testing parameters and high-resolution CT fibrosis scores) must be adjusted to assess the cancer-specific predictive value of KL-6 for lung cancer combined with ILD. The gene discussed is MUC1; the disease is lung carcinoma.